TAK-070 (Free base)
TAK-070 Free base is a noncompetitive and orally active BACE1 inhibitor (IC50: 3.15 μM) . TAK-070 Free base can be used for research of Alzheimer’s disease (AD) . TAK-070 Free base inhibits brain levels of soluble Aβ, and improves cognitive impairments in AD model[1].
Product Specifications
CAS Number
212571-56-7
UNSPSC
12352005
Target
Amyloid-β; Beta-secretase
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tak-070-free-base.html
Solubility
10 mM in DMSO
Smiles
CN(CC[C@H]1CC2=C(CC1)C=C(C=C2)OCC3=CC=C(C=C3)C4=CC=CC=C4)C
Molecular Formula
C27H31NO
Molecular Weight
385.54
References & Citations
[1]Fukumoto H, et al. A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease. J Neurosci. 2010 Aug 18;30 (33) :11157-66.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BACE1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY427983 100 µg
alpha smooth muscle Actin (ACTA2) (NM_001141945) Human Over-expression Lysate
Sign In for Pricing
View Details 